Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Cash & Equivalents (2023 - 2025)

SeaStar Medical Holding's Cash & Equivalents history spans 3 years, with the latest figure at $12.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 559.7% year-over-year to $12.0 million; the TTM value through Dec 2025 reached $12.0 million, up 559.7%, while the annual FY2025 figure was $12.0 million, 559.7% up from the prior year.
  • Cash & Equivalents reached $12.0 million in Q4 2025 per ICUCW's latest filing, down from $13.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $13.8 million in Q3 2025 to a low of $13000.0 in Q2 2023.
  • Average Cash & Equivalents over 3 years is $4.0 million, with a median of $2.0 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: soared 8969.23% in 2024, then rose 5.6% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $176000.0 in 2023, then surged by 933.52% to $1.8 million in 2024, then skyrocketed by 559.7% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Cash & Equivalents are $12.0 million (Q4 2025), $13.8 million (Q3 2025), and $6.3 million (Q2 2025).